Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria
1 other identifier
interventional
1,000
1 country
2
Brief Summary
This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2016
CompletedFirst Submitted
Initial submission to the registry
June 8, 2017
CompletedFirst Posted
Study publicly available on registry
June 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2019
CompletedNovember 30, 2022
November 1, 2022
2.7 years
June 8, 2017
November 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication reconciliation: Percentage unreconciled medications
Percentage unreconciled medications
3 months
Study Arms (2)
Intervention arm
EXPERIMENTALSeminar presentation will be done using the followings: 1. Power point presentation on the following topics as it relates to medication reconciliation: 1. Communication skill (with patients and also with other members of the healthcare team) 2. Documentation of pharmaceutical care activities 3. Medication history taking 4. Drug therapy problems 5. Medication reconciliation practice 2. Case studies on medication reconciliation 3. Role plays on medication reconciliation
Control arm
NO INTERVENTIONControl group
Interventions
Eligibility Criteria
You may qualify if:
- Participant has diabetes and/or hypertension
- Registered pharmacists in the selected institutions
You may not qualify if:
- Participants that are neither diabetic nor hypertensive
- Unregistered pharmacists in the selected institutions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Ilorin Teaching Hospital
Ilorin, Kwara State, Nigeria
University College Hospital
Ibadan, Oyo State, 2334, Nigeria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
TITILAYO O FAKEYE, PhD
University of Ibadan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Masking Details
- Both the patients and the pharmacists recruited for the study will not be informed whether they are in the control or intervention group
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer II
Study Record Dates
First Submitted
June 8, 2017
First Posted
June 9, 2017
Study Start
August 2, 2016
Primary Completion
April 30, 2019
Study Completion
April 30, 2019
Last Updated
November 30, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share